191.033 articles found

Impulse Control Disorders and Other Compulsive Behaviours in Parkinson’s Disease – What Is Current Evidence of Treatment?

Gross A.

BJPsych open · 2025-06-20

Parkinson’s Disease With Psychosis: A Case Report of Neuropsychiatric Manifestations

Alewad S.

BJPsych open · 2025-06-20

Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson's disease and OFF episodes: post hoc analyses of a phase III, open-label study.

Kassubek J, Santos Garcia D, Jost WH, Wojtecki L, Moreira F, Fonseca MM, Harrison-Jones G, Pijuan I, Denecke Muhr C.

Ther Adv Neurol Disord · 2025-06-20

DOI: 10.1177/17562864251343583PMID: 40547865

Evaluation of the potential therapeutic effect of africanized honeybee venom (Apis mellifera Linnaeus) on levodopa-induced dyskinesias in mice.

Dantas CG, Araújo AAS, DE Albuquerque Junior RLC, Cândido EAF, Gomes MZ, Costa LPD.

An Acad Bras Cienc · 2025-06-20

DOI: 10.1590/0001-3765202520240826PMID: 40561270

Insights into gait performance in Parkinson's disease via latent features of deep graph neural networks.

Wu J, Su N, Li X, Yao C, Zhang J, Zhang X, Sun W.

Front Neurol · 2025-06-20

DOI: 10.3389/fneur.2025.1567344PMID: 40621096

Age-specific effects of synthetic cannabinoids on cognitive function and hippocampal gene expression in mice: insights from behavioral and molecular correlates.

Li K, Chen Y, Xu Y, Pang Y, Bao Y, Zhang S, Shi X, Ran J, Qiao Y, Xu Y, Wang Y, Di B, Xu P.

Front Pharmacol · 2025-06-20

DOI: 10.3389/fphar.2025.1618929PMID: 40626303

Unraveling α-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson's disease.

Zhou Y, Lai M, Shu B, Wang B, Wang D, Liu H, Li B, Guo J, Hu D, Li M, Zhu C, Kang M, Li ZA, Wang R, Zhao Y, Tuan RS, Guo K, Li C, Jiang C.

Theranostics · 2025-06-20

DOI: 10.7150/thno.112396PMID: 40756347

Breaking geographic and language barriers in neuropsychology: online administration of MoCA in diverse populations.

Gilad T, Algon AL, Vakil E, Kitany S, Gharra R, Higaze R, Leavitt VM, Saban W.

NPJ Digit Med · 2025-06-20

DOI: 10.1038/s41746-025-01787-9PMID: 40537516

Suffering and loss in Lewy body dementia: Applying a palliative care lens to a longitudinal narrative study.

Bentley A, Salifu Y, Walshe C.

Palliat Support Care · 2025-06-20

DOI: 10.1017/s1478951524001962PMID: 40538366

A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets.

Vaiana A, Behr J, Birol R, Blauwendraat C, Casey B, Chowdhury K, Citron M, Crapser J, Dardov V, Ducotterd F, Dumanis S, Dunlop J, Durborow M, Fiske B, Golden J, Hannestad J, Hung W, Kemp J, Kleiman R, Knight A, Koemeter-Cox A, Leuchter B, Logsdon BA, Marreiros R, Miller JE, Mitchell A, Mukherjee P, Navarro G, Nelson MR, Nikolich K, Otis T, Polinski N, Rastegar-Pouyani S, Reith AD, Riley E, Rubin L, Ryten M, Sadick J, Schwabe T, Sherer T, Silvergleid S, Singleton A, St Clair L, Stoehr J, Stone DJ, Sullivan J, Tanenbaum N, Tinelli E, Trimble K, Wang Y, Weninger S, Wiggenhauser N, Wood S, Schoepp D, Buggia-Prevot V, Padmanabhan S, Skibinski G.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-01039-3PMID: 40541945

Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction.

Chedid J, Li Y, Labrador-Garrido A, Abu-Bonsrah D, Pavan C, Fraser T, Ovchinnikov D, Zhong M, Davis R, Strbenac D, Johnston JA, Thompson LH, Kirik D, Parish CL, Halliday GM, Sue CM, Wali G, Dzamko N.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-01048-2PMID: 40541941

Saliva as a potential diagnostic medium: DNA methylation biomarkers for disorders beyond the oral cavity.

Hernangomez-Laderas A, Cilleros-Portet A, Marí S, González-García BP, Arregi A, Jimeno-Romero A, Irizar A, García-Santisteban I, Lesseur C, Fernandez-Jimenez N, Bilbao JR.

NPJ Genom Med · 2025-06-20

DOI: 10.1038/s41525-025-00509-0PMID: 40541940